78 related articles for article (PubMed ID: 9200333)
1. Synthesis and biological effects of N-alkylamine-labeled low-molecular-mass dermatan sulfate.
Malsch R; Guerrini M; Berti C; Naggi A; Torri G; Casu B; Harenberg J
Semin Thromb Hemost; 1997; 23(2):99-107. PubMed ID: 9200333
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of a N'-alkylamine anticoagulant active low-molecular-mass heparin for radioactive and fluorescent labeling.
Malsch R; Guerrini M; Torri G; Löhr G; Casu B; Harenberg J
Anal Biochem; 1994 Mar; 217(2):255-64. PubMed ID: 8203754
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula).
Ben Mansour M; Dhahri M; Bertholon I; Ollivier V; Bataille I; Ajzenberg N; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):887-94. PubMed ID: 19019412
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin and dermatan sulfate end group-labeled with tyramine and fluorescein. Biochemical and biological characterization of the fluorescent-labeled heparin derivative.
Harenberg J; Casu B; Guerrini M; Malsch R; Naggi A; Piazolo L; Torri G
Semin Thromb Hemost; 2002 Aug; 28(4):343-54. PubMed ID: 12244481
[TBL] [Abstract][Full Text] [Related]
5. The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities.
Du HY; Ji SL; Song HF; Ye QN; Cao JC
Thromb Res; 2007; 119(3):377-84. PubMed ID: 17097136
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC
Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
[TBL] [Abstract][Full Text] [Related]
7. The additive effect of low molecular weight heparins on thrombin inhibition by dermatan sulfate.
Cosmi B; Agnelli G; Young E; Hirsh J; Weitz J
Thromb Haemost; 1993 Sep; 70(3):443-7. PubMed ID: 8259546
[TBL] [Abstract][Full Text] [Related]
8. Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: anticoagulant activity and mechanism of action.
Ben Mansour M; Dhahri M; Hassine M; Ajzenberg N; Venisse L; Ollivier V; Chaubet F; Jandrot-Perrus M; Maaroufi RM
Comp Biochem Physiol B Biochem Mol Biol; 2010 Jul; 156(3):206-15. PubMed ID: 20363356
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
Dol F; Petitou M; Choay J; Sie P; Houin G; Boneu B
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):851-7. PubMed ID: 2483702
[TBL] [Abstract][Full Text] [Related]
10. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities.
Linhardt RJ; al-Hakim A; Liu JA; Hoppensteadt D; Mascellani G; Bianchini P; Fareed J
Biochem Pharmacol; 1991 Sep; 42(8):1609-19. PubMed ID: 1930287
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant activity of a dermatan sulfate from the skin of the shark Scyliorhinus canicula.
Dhahri M; Mansour MB; Bertholon I; Ollivier V; Boughattas NA; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):547-57. PubMed ID: 20581662
[TBL] [Abstract][Full Text] [Related]
12. Structural characterization and antithrombin activity of dermatan sulfate purified from marine clam Scapharca inaequivalvis.
Volpi N; Maccari F
Glycobiology; 2009 Apr; 19(4):356-67. PubMed ID: 19056786
[TBL] [Abstract][Full Text] [Related]
13. N-Acetylgalactosamine 4,6-O-sulfate residues mediate binding and activation of heparin cofactor II by porcine mucosal dermatan sulfate.
Halldórsdóttir AM; Zhang L; Tollefsen DM
Glycobiology; 2006 Aug; 16(8):693-701. PubMed ID: 16624894
[TBL] [Abstract][Full Text] [Related]
14. Structural composition and differential anticoagulant activities of dermatan sulfates from the skin of four species of rays, Dasyatis americana, Dasyatis gutatta, Aetobatus narinari and Potamotrygon motoro.
Dellias JM; Onofre GR; Werneck CC; Landeira-Fernandez AM; Melo FR; Farias WR; Silva LC
Biochimie; 2004; 86(9-10):677-83. PubMed ID: 15556278
[TBL] [Abstract][Full Text] [Related]
15. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
Castañon MM; Gamba C; Kordich LC
Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
17. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
[TBL] [Abstract][Full Text] [Related]
18. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
[TBL] [Abstract][Full Text] [Related]
19. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of deuterium-labeled glycosaminoglycans.
Naggi A; Casu B; Crippa B; Magnaghi S; Silvestro L; Torri G
Semin Thromb Hemost; 1994; 20(2):168-75. PubMed ID: 7997888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
